UEG - United European Gastroenterology

Session

IBD (Posters)

A 12-WEEK TAILORED PHYSICAL TRAINING PROGRAM INCLUDING DIETARY ADVICE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A RANDOMIZED CROSSOVER TRIAL.

Linda Elisabeth Scheffers, Johanna C Escher, Linda Elisabeth van den Berg, Mariëlle W Pijnenburg, Wim A Helbing, E.M. Utens, G.C. Dielemans, A.T. Ploeg

A 12-WEEK TAILORED PHYSICAL TRAINING PROGRAM INCLUDING DIETARY ADVICE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A RANDOMIZED CROSSOVER TRIAL.

Linda Elisabeth Scheffers

A HIGHER INDUCTION DOSING REGIMEN OF ADALIMUMAB DOES NOT ENHANCE MODULATION OF DOWNSTREAM BLOOD MOLECULAR MARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE OR ULCERATIVE COLITIS: RESULTS FROM THE SERENE-CD AND SERENE-UC STUDIES

A HIGHER INDUCTION DOSING REGIMEN OF ADALIMUMAB DOES NOT ENHANCE MODULATION OF DOWNSTREAM BLOOD MOLECULAR MARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE OR ULCERATIVE COLITIS: RESULTS FROM THE SERENE-CD AND SERENE-UC STUDIES

Marc Ferrante, Valerie Pivorunas, James Butler, Naim Mahi, Nael M. Mostafa, Melanie Ruzek, James Fann, Feng Hong, Xiaohong Cao, Nizar Smaoui, Justin Wade Davis, Jasmina Kalabic, Alexandra Song, Heath M. Guay, Florian Rieder, Julian Panés, Jean-Frédéric Colombel

A MATCHING-ADJUSTED INDIRECT COMPARISON OF MAINTENANCE ORAL FILGOTINIB VERSUS INTRAVENOUS VEDOLIZUMAB FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

A MATCHING-ADJUSTED INDIRECT COMPARISON OF MAINTENANCE ORAL FILGOTINIB VERSUS INTRAVENOUS VEDOLIZUMAB FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Vipul Jairath, James Lindsay, Emma Gray, Yiqiao Xin, Zheng-Yi Zhou, Min-Jung Wang, Xiaoyan Lu

A PILOT STUDY ON THE USE OF USTEKINUMAB IN REFRACTORY PERIANAL CROHN'S DISEASE

Federica Crispino

A PILOT STUDY ON THE USE OF USTEKINUMAB IN REFRACTORY PERIANAL CROHN’S DISEASE

Federica Crispino, DANIELE BRINCH, Lucio Carrozza, Maria Cappello, Anita Busacca, Gianfranco Cocorullo

A RANDOMIZED, PLACEBO CONTROLLED, DOUBLE BLINDED, CROSS OVER FODMAP PROVOCATION IN PATIENTS WITH ULCERATIVE COLITIS AND IRRITABLE BOWEL SYNDROME ON A LOW FODMAP DIET

Anne Lund Krarup

A RANDOMIZED, PLACEBO CONTROLLED, DOUBLE BLINDED, CROSS OVER FODMAP PROVOCATION IN PATIENTS WITH ULCERATIVE COLITIS AND IRRITABLE BOWEL SYNDROME ON A LOW FODMAP DIET

Anne Lund Krarup, Dorte Melgaard, Peter Leutscher, Johannes Riis, Suzette Sørensen, Jeanette Sørensen, Mette Borre

A REAL-WORLD EVALUATION OF TOFACITINIB FOR ULCERATIVE COLITIS IN UK AND IRELAND

A REAL-WORLD EVALUATION OF TOFACITINIB FOR ULCERATIVE COLITIS IN UK AND IRELAND

Richard Howard, Andrew Spence, Patrick Allen

A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFICACY AND SAFETY OF INFLIXIMAB AND VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Laurent Peyrin-Biroulet

A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFICACY AND SAFETY OF INFLIXIMAB AND VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Laurent Peyrin-Biroulet, Alessandro Armuzzi, Raja Atreya, Silvio Danese, Jordi Guardiola, Jørgen Jahnsen, Charlie Lees, Edouard Louis, Milan Lukas, Walter Reinisch, Xavier Roblin, Minyoung Jang, Han Geul Byun

A TERTIARY MULTICENTER COHORT OF PATIENTS WITH CHRONIC INTESTINAL PSEUDO-OBSTRUCTION AND CROHN'S DISEASE: A RARE ASSOCIATION WITH A HIGH PREVALENCE OF MONOGENIC DISORDERS

Flore De Castelbajac

A TERTIARY MULTICENTER COHORT OF PATIENTS WITH CHRONIC INTESTINAL PSEUDO-OBSTRUCTION AND CROHN’S DISEASE: A RARE ASSOCIATION WITH A HIGH PREVALENCE OF MONOGENIC DISORDERS

Xavier Treton, Flore De Castelbajac, Carmen Stefanescu, Dominique Cazals-Hatem, Lore Billiauws, Yoram Bouhnik, Francisca Joly, Mathieu Uzzan, Fabienne Charbit-Henrion, Olivier Goulet

ABNORMAL FRAILTY SCREENING IS INDEPENDENTLY ASSOCIATED WITH BOTH ALL-CAUSE AND DISEASE-RELATED HOSPITAL ADMISSIONS IN OLDER PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Martine Baven-Pronk, Rutger Jacobs, Rogier Stuyt, Vera Asscher, Sanne Waars, Jesse Fens, Monse Wieland, Andrea E. Van Der Meulen - De Jong, Sander van der Marel, Jeoffrey Haans, Floor van Deudekom, Simon Mooijaart, Jeroen Maljaars

ACCEPTANCE OF SWITCH, PATIENT SATISFACTION AND ADVERSE EVENTS AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR SB5 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A REAL-LIFE SETTING

Thomas De Somer, Didier Baert, Mieke Deceuninck, Inge Huys, Veerle Mattens, An Sterckx, Erik Vanderstraeten, Jo Vandervoort, Nina Van Heddegem, Pieter Dewint, Nele Deprez, Stijn Vanden Branden

ACCEPTANCE OF SWITCH, PATIENT SATISFACTION AND ADVERSE EVENTS AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR SB5 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A REAL-LIFE SETTING

Thomas De Somer

ADALIMUMAB 80MG EVERY OTHER WEEK IN INFLAMMATORY BOWEL DISEASE: TREATMENT INTENSIFICATION OUTCOMES IN REAL LIFE CLINICAL PRACTICE

Elena Santos Perez, Yago González Lama, Ignacio Omella Usieto, Ismael El Hajra Martinez, Belen Ruiz Antoran, Belén Menchen Viso, Marta Isabel Calvo Moya, Virginia Matallana Royo, Irene González Partida, Rocío De Lucas Téllez de Meneses, Macerena Gonzalez Rodriguez, Maria Isabel Vera Mendoza, Pablo Bella del Castillo

ADALIMUMAB 80MG EVERY OTHER WEEK IN INFLAMMATORY BOWEL DISEASE: TREATMENT INTENSIFICATION OUTCOMES IN REAL LIFE CLINICAL PRACTICE

Marta Isabel Calvo Moya

ADALIMUMAB TROUGH LEVELS DURING INDUCTION ARE NOT ASSOCIATED WITH BIOCHEMICAL REMISSION IN PATIENTS WITH CROHN'S DISEASE

Jose Luis Rueda García

ADALIMUMAB TROUGH LEVELS DURING INDUCTION ARE NOT ASSOCIATED WITH BIOCHEMICAL REMISSION IN PATIENTS WITH CROHN’S DISEASE

Laura García Ramírez, Tamara Verges, María Dolores Martín-Arranz, Jesús Noci, Cristina Suárez Ferrer, Eduardo Martín-Arranz, Joaquin Poza Cordon, Jose Luis Rueda García, Maria Sanchez-Azofra, Paula Blanco San Miguel, Jose Manuel Belmonte Rodríguez

ADHERENCE TO MESALAZINE AND IDENTIFICATION OF PATIENTS WITH ULCERATIVE COLITIS IN HEALTHCARE ADMINISTRATIVE DATABASES OF TUSCANY (ITALY)

Claudia Bartolini, Sara Ferraro, Lorenzo Bertani, Irma Convertino, Sabrina Giometto, Silvia Tillati, Giulia Valdiserra, Emiliano Cappello, Ersilia Lucenteforte, Rosa Gini, Marco Tuccori, Francesco Costa, Corrado Blandizzi

ADHERENCE TO MESALAZINE AND IDENTIFICATION OF PATIENTS WITH ULCERATIVE COLITIS IN HEALTHCARE ADMINISTRATIVE DATABASES OF TUSCANY (ITALY)

Lorenzo Bertani

ADHERENCE TO VACCINATION RECOMMENDATIONS IN INFLAMMATORY BOWEL DISEASE PATIENT: A LONG WAY FOR IMPROVING.

Rocío Ferreiro-Iglesias

ADHERENCE TO VACCINATION RECOMMENDATIONS IN INFLAMMATORY BOWEL DISEASE PATIENT: A LONG WAY FOR IMPROVING.

Roberto Saldana, Iago Rodríguez-Lago, Alejandro Hernandez Camba, Manuel Barreiro de Acosta, Rocío Ferreiro-Iglesias, Yamile Zabana Abdo

AGE MAY NOT IMPACT BIOLOGIC TREATMENT FAILURE AT 12 MONTHS FOR INFLAMMATORY BOWEL DISEASE: A REAL LIFE RETROSPECTIVE SINGLE CENTRE COHORT STUDY

AGE MAY NOT IMPACT BIOLOGIC TREATMENT FAILURE AT 12 MONTHS FOR INFLAMMATORY BOWEL DISEASE: A REAL LIFE RETROSPECTIVE SINGLE CENTRE COHORT STUDY

Sonika Sethi, Jayesh Patel, Jonathan Bruce, Duaa Dhafer, Mohammed Suleman, Amy Thompson, Peter Nightingale, Shyam Menon, Hari Padmanabhan, Sunenah Verma, Matthew James Brookes

AI AUTOMATED WORKFLOW FOR IMPROVING DETECTION AND SCORING OF ULCERATIVE COLITIS DISEASE ACTIVITY UNDER MULTIPLE SCORING SYSTEMS

Milagros Henkel

ALICAFORSEN ENEMA IN CHRONIC POUCHITIS: RESULTS OF A PHASE 3 RANDOMIZED, DOUBLE BLIND PLACEBO-CONTROLLED TRIAL

Nermeen Varawalla, James Lindsay, Brian Feagan, Gordon Moran

AN AUDIT OF PROACTIVE THERAPEUTIC DRUG MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGICS

AN AUDIT OF PROACTIVE THERAPEUTIC DRUG MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGICS

Jane Mccarthy, Kathleen Sugrue, Kee Bin Ng, Martin Buckley, Carthage Moran, Sarah Gleeson, Caitriona O Sullivan, John O Grady, Anne Fennessy

ANALYSIS OF INFECTIONS OF INTEREST IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME

Alessandro Armuzzi, Christina Ha, Michael Chiorean, Nervin Lawendy, Rajiv Mundayat, Leonardo Salese, John C. Woolcott, Chinyu Su, Iris Dotan

ANALYSIS OF INFECTIONS OF INTEREST IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME

ANCA-ASSOCIATED VASCULITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: ONE OF THE PREDICTORS OF SEVERE COURSE AND REASONS FOR NON-RESPONSE TO BASIC THERAPY

Gunay Asadova, Umud Makhmudov, Emin Mammadov, Khalida Ismayilova, Zeynal Babayev, Orkhan Mirzazade, Tunzala Samadova, Ulvi Machanov, Farid Quliyev, Aychin Hasanova, Gulustan Babayeva

ANCA-ASSOCIATED VASCULITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: ONE OF THE PREDICTORS OF SEVERE COURSE AND REASONS FOR NON-RESPONSE TO BASIC THERAPY

Gulustan Babayeva

ANTIOXIDANT VITAMINS AND ELECTROLYTES INCREASED INTAKE IS ASSOCIATED WITH LOWER DISEASE ACTIVITY AND BETTER QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Ioanna Pefkianaki, Ioannis Mouzas, Ioannis Koutroubakis

ANTIOXIDANT VITAMINS AND ELECTROLYTES INCREASED INTAKE IS ASSOCIATED WITH LOWER DISEASE ACTIVITY AND BETTER QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Ioanna Pefkianaki

ARTIFICIAL INTELLIGENCE SURPASSES GASTROINTESTINAL EXPERTS IN THE CLASSIFICATION OF ENDOSCOPIC SEVERITY AMONG ULCERATIVE COLITIS

Flemming Bendtsen, Bobby Lo, Christian Igel, Ida Vind, ZhuoYuan Liu, Johan Burisch

ARTIFICIAL INTELLIGENCE SURPASSES GASTROINTESTINAL EXPERTS IN THE CLASSIFICATION OF ENDOSCOPIC SEVERITY AMONG ULCERATIVE COLITIS

ASSESSEMENT OF CUMULATIVE BOWEL DAMAGE USING LEMANN INDEX AND MARIA SCORE IN SURGICALLY NAIVE PATIENTS WITH CROHN'S DISEASE

Viktor Domislovic

ASSESSEMENT OF CUMULATIVE BOWEL DAMAGE USING LEMANN INDEX AND MARIA SCORE IN SURGICALLY NAIVE PATIENTS WITH CROHN'S DISEASE

Viktor Domislovic, Kristina Hrabric Sonje, Niksa Turk, Dora Grgic, Marko Brinar, Silvija Cukovic-Cavka, Ivica Sjekavica, Zeljko Krznaric

ASSESSMENT OF SARCOPENIA AND NUTRITIONAL STATUS IN A COHORT OF PATIENTS WITH CROHN'S DISEASE

Olga Maria Nardone

ASSESSMENT OF SARCOPENIA AND NUTRITIONAL STATUS IN A COHORT OF PATIENTS WITH CROHN’S DISEASE

Roberto de Sire, Olga Maria Nardone, Andrea Ponsiglione, Antonio Rispo, Anna Testa, Guido Daniele Villani, Luigi Camera, Fabiana Castiglione

ASSESSMENT OF THE DEGREE OF INTESTINAL DESTRUCTION IN CROHN'S DISEASE AT THE TIME OF DIAGNOSIS

Soumaya Mrabet, Imen Akkari, Amani Hassine, Elhem Ben Jazia

ASSESSMENT OF THE DEGREE OF INTESTINAL DESTRUCTION IN CROHN'S DISEASE AT THE TIME OF DIAGNOSIS

ASSOCIATION BETWEEN DAILY INTAKE OF ADDED SUGAR AND DISEASE ACTIVITY OR QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Ioanna Pefkianaki, Ioannis Mouzas, Ioannis Koutroubakis

ASSOCIATION BETWEEN DAILY INTAKE OF ADDED SUGAR AND DISEASE ACTIVITY OR QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Ioanna Pefkianaki

Item 1 - 50 / 579

1

2 3 4 5 6 7

...

11 12